Maintenance chemotherapy in limited small cell lung cancer: a randomised controlled clinical trial.

por Byrne, M. J., van Hazel, G., Trotter, J., Cameron, F., Shepherd, J., Cassidy, B., Gebski, V.
Publicado 1989

Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer

por Goldstein, D, Van Hazel, G, Walpole, E, Underhill, C, Kotasek, D, Michael, M, Shapiro, J, Davies, T, Reece, W, Harvey, J, Spry, N
Publicado 2007

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

por Tebbutt, N C, Cummins, M M, Sourjina, T, Strickland, A, Van Hazel, G, Ganju, V, Gibbs, D, Stockler, M, Gebski, V, Zalcberg, J
Publicado 2010

Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial

por Tebbutt, N C, Parry, M M, Zannino, D, Strickland, A H, Van Hazel, G A, Pavlakis, N, Ganju, V, Mellor, D, Dobrovic, A, Gebski, V J
Publicado 2013

Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab

por Siena, S, Peeters, M, Van Cutsem, E, Humblet, Y, Conte, P, Bajetta, E, Comandini, D, Bodoky, G, Van Hazel, G, Salek, T, Wolf, M, Devercelli, G, Woolley, M, Amado, R G
Publicado 2007

Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or...

por Price, T J, Bruhn, M A, Lee, C K, Hardingham, J E, Townsend, A R, Mann, K P, Simes, J, Weickhardt, A, Wrin, J W, Wilson, K, Gebski, V, Van Hazel, G, Robinson, B, Cunningham, D, Tebbutt, N C
Publicado 2015

The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pa...

por Goldstein, D, Spry, N, Cummins, M M, Brown, C, van Hazel, G A, Carroll, S, Selva-Nayagam, S, Borg, M, Ackland, S P, Wratten, C, Shapiro, J, Porter, I W T, Hruby, G, Horvath, L, Bydder, S, Underhill, C, Harvey, J, Gebski, V J
Publicado 2012

Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial

por Garlipp, B., Gibbs, P., Van Hazel, G. A., Jeyarajah, R., Martin, R. C. G., Bruns, C. J., Lang, H., Manas, D. M., Ettorre, G. M., Pardo, F., Donckier, V., Benckert, C., van Gulik, T. M., Goéré, D., Schoen, M., Pratschke, J., Bechstein, W. O., de la Cuesta, A. M., Adeyemi, S., Ricke, J., Seidensticker, M.
Publicado 2019